3-Sulfonylamino-Pyrrolidine-2-One Derivatives as Factor Xa Inhibitors
申请人:Harling John David
公开号:US20090099231A1
公开(公告)日:2009-04-16
The present invention provides pyrrolidinone derivatives as Factor Xa inhibitors and pharmaceutical compositions comprising the same. The invention also relates to processes for the preparation of such compounds, and the use of such compounds in medicine, particularly in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.